Details of the Drug Formulaction

General Information of Drug Formulation (ID: F12689)

• Formulation Name: Lubiprostone 0.008 mg capsule
• Company: Takeda Pharmaceuticals America

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Lubiprostone	(DMJTEMW)	Chronic idiopathic constipation	DC32	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Eisenoxyd	(E00585)	56841934	Colorant
Hexahydric alcohol	(E00083)	5780	Diluent; Flavoring agent; Humectant; Plasticizing agent
Medium-chain triglyceride	(E00640)	Not Available	Emollient; Lubricant; Surfactant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Water	(E00035)	962	Solvent